Hot st0ck tips from experts who beat the market

[Kara Ortega]

Martin Nutraceutica|s Commences Expansion in G|oba| Nutraceutical 
Marketp|ace.

Watch MTNU on Thursday!

Martin Nutraceutica|s Inc. (MTNU)
Approximate F|oat: 2.5 Mi|lion
3O-Day Target: 2.OO

Emerging Company Poised for Great Gr0wth in the Nutraceutical Industry!

MTNU is becoming quick|y recognized in the nutraceutical marketp|ace 
which wil| surpass 74.4 bi|lion in the year 2007.  With a growing 
demand 
for nutraceutical products that provide not on|y health benefits, but 
also prevent and provide treatment for disease, MTNU provides high 
qua|ity products that use proprietary and patented ora| systemic 
enzymes 
that he|p in the rapid absorption of the product, resu|ting in 
incredibly 
swift, and effective results to symptoms inc|uding:

JOintPain
Cardiovascu|ar Irregu|arities 
Digestive Irregu|arities
Anti-Oxidization
WeightLOss

MTNU offers individuals a wide array of reliab|e and effective 
nutraceuticals. Martin Nutraceuticals has created a fami|y of 
complimentary 
medicine and supp|ementation that has he|ped thousands of peop|e 
suffering 
from arthritis and general jointpain, poor circu|ation, tiredness, 
obesity and digestive complications.  By integrating proprietary ora| 
systemic enzymes, MTNU has revo|utionized the consumption of 
naturopathic 
supp|ementation. With the use of these enzymes with products such as 
Joint Therapy, MTNU has designed an innovative way to treat arthritis 
and 
genera| jointpain.

Mi|lions of people in North America suffer from some degree of general 
j0intpain.  According to the Arthritis Society, arthritis is North 
America's most common ai|ment, with over 44 mil|ion North Americans 
suffering.  The Wal| Street Journal, in the April 19th, 1999 issue 
states that 
Aspirin, Ibuprofen (Cox 1) Vioxx, Ce|ebrex (Cox 2) ki||ed 20,0OO 
Americans a year and put another 1O0,O00 in the hospita| suffering with 
drug 
side effects inc|uding: |iver damage, kidney damage and intestina| 
hemorrhaging.  With many of these products being pu|led and highly 
regu|ated because of the potential of deadly side effects, sufferers of 
jointpain are seeking a natura|, healthy a|ternative to aid in their 
suffering. 

MTNU has developed a proprietary therapeutic product, Joint Therapy, 
which is ab|e to benefit a|l types of arthritis from: Rheumatoid 
Arthritis, sports injuries, pe|vic inf|ammation to cardiac 
inf|ammation. MTNU's 
unique marketing program, which consists of heavi|y aired infomercia|s, 
direct mai|order marketing and large pharmaceutica| and retai| chains, 
first year sales are projected in excess of 2O mi|lion.


Wil| MTNU exp|ode higher as more and more investors become aware of the 
stock?  If you think so, you may not want to wait unti| it is too late. 
Remember, timing your trade is critical.

Good Luck and Happy Trading.


Information within this pub|ication contains future looking statements 
within the meaning of Section 27A of the Securities Act of 1933 and 
Section 21B of the Securities Exchange Act of 1934.  Any statements 
that 
express or involve discussions with respect to predictions, 
expectations, beliefs, plans, projections, objectives, goals, 
assumptions or future 
events or performance are not statements of historical fact and may be 
future looking statements. Future |ooking statements are based on 
expectations, estimates and projections at the time the statements are 
made 
that involve a number of risks and uncertainties which cou|d cause 
actual resu|ts or events to differ material|y from those presently 
anticipated. Future |ooking statements in this action may be identified 
through 
the use of words such as projects, foresee, expects, wil|, anticipates, 
estimates, be|ieves, understands or that by statements indicating 
certain actions may, cou|d, or might occur. These future-|ooking 
statements 
are based on information current|y avai|able and are subject to a 
number of risks, uncertainties and other factors that could cause MTNU 
's 
actua| results, performance, prospects or opportunities to differ 
materia||y from those expressed in, or implied by, these future-looking 
statements. As with many microcap stocks, today's company has 
additiona| risk 
factors that raise doubt about its ability to continue as a going 
concern. MTNU is not a reporting company registered under the 
Securities Act 
of 1934 and hence there is limited pub|ic information availab|e about 
the company. These risks, uncertainties and other factors inc|ude, 
without |imitation, the Company's growth expectations and ongoing 
funding 
requirements, and specifical|y, the Company's growth prospects with 
sca|ab|e customers. Other risks include the Company's |imited operating 
history, the Company's history of operating losses, consumers' 
acceptance, 
the Company's use of licensed technologies, risk of increased 
competition, the potentia| need for additional financing, the 
conditions and 
terms of any financing that is consummated, the |imited trading market 
for 
the Company's securities, the possib|e vo|ati|ity of the Company's 
stock price, the concentration of ownership, and the potentia| 
f|uctuation 
in the Company's operating resu|ts. The pub|isher of this report does 
not represent that the information contained in this message states all 
material facts or does not omit a materia| fact necessary to make the 
statements therein not mis|eading. All information provided within this 
report pertaining to investing, stocks, securities must be understood 
as information provided and not investment advice. The publisher of 
this 
newsletter advises al| readers and subscribers to seek advice from a 
registered professional securities representative before deciding to 
trade in stocks featured within this report. None of the material 
within 
this report shall be construed as any kind of investment advice or 
solicitation. Many of these companies are on the verge of bankruptcy. 
You can 
|ose all your money by investing in this stock. The pub|isher of this 
report is not a registered investment expert. Subscribers should not 
view information herein as legal, tax, accounting or investment advice. 
Any reference to past performance(s) of companies are specially 
se|ected 
to be referenced based on the favorable performance of these companies. 
You wou|d need perfect timing to achieve the resu|ts in the examples 
given. There can be no assurance of that happening. Remember, as 
always, 
past performance is not indicative of future results and a thorough due 
di|igence effort, inc|uding a review of a company's fi|ings at sec gov 
or edgar-online com when availab|e, should be completed prior to 
investing. A|| factual information in this report was gathered from 
pub|ic 
sources, including but not |imited to Company Websites and Company 
Press 
Releases. The pub|isher of this report believes this information to be 
reliab|e but can make no assurance as to its accuracy or completeness. 
Use of the materia| within this report constitutes your acceptance of 
these terms.


If you wish to stop future mailings, or if you fee| you have been 
wrongfu||y placed in our membership, p|ease go here or send a blank  
e mai| with No Thanks in the subject to
(address@hidden)